Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Oncology|April 28, 2023
Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in JapanKazutaka Yamada, Kouya Shiraishi, Atsuo Takashima, et al.
Cancers|April 3, 2021
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the CervixDaisuke Takayanagi, Sou Hirose, Ikumi Kuno, et al.
Scientific Reports|September 29, 2021
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancerIkumi Kuno, Daisuke Takayanagi, Yuka Asami, et al.
Scientific Reports|November 8, 2022
Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancerYuka Asami, Kengo Hiranuma, Daisuke Takayanagi, et al.
JNCI Cancer Spectrum|April 11, 2026
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancerErika Machida, Yasuyuki Takamizawa, Daisuke Takayanagi, et al.
Cancer Genomics & Proteomics|December 27, 2024
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint InhibitorsTomoyuki Ishiguro, Kazuyuki Takeda, Daisuke Takayanagi, et al.
Biomedicines|December 24, 2021
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 AntibodiesRyotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, et al.
Clinical Lung Cancer|March 16, 2021
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine CarcinomaMasayuki Shirasawa, Tatsuya Yoshida, Daisuke Takayanagi, et al.
Scientific Reports|May 20, 2021
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapyNaoya Murakami, Yuka Asami, Hiroshi Yoshida, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2021
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Yukiko Shimoda, et al.
Pageof 4